Published in Liver Transpl Surg on January 01, 1999
Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46
De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45
Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation. Dig Dis Sci (2007) 0.86
A case report of de novo hepatocellular carcinoma after living donor liver transplantation. World J Surg Oncol (2013) 0.78
Management of de novo hepatocellular carcinoma developing in a transplanted liver. Dig Dis Sci (2007) 0.75
De novo Hepatocellular Carcinoma after Liver Transplantation. J Clin Transl Hepatol (2015) 0.75
Nephrectomy for a renal metastasis of undiagnosed hepatocellular carcinoma arising from an orthotopic liver transplant undertaken for cryptogenic cirrhosis. Korean J Urol (2013) 0.75
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med (1991) 4.68
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab (1999) 3.00
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med (1989) 2.09
Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07
HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med (1992) 2.03
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol (1980) 1.64
One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg (2001) 1.61
Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol (2000) 1.59
Telomerase activity in precancerous hepatic nodules. Cancer (1998) 1.59
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol (2000) 1.56
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53
N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52
Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet (1990) 1.49
Brucella infection with pancytopenia after pediatric liver transplantation. Transpl Infect Dis (2012) 1.45
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44
The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr (2001) 1.43
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Molecular and cellular pathology of hepatitis B. Lab Invest (1985) 1.43
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med (1998) 1.42
HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol (1993) 1.42
Distribution of five antigens in hepatocellular carcinoma. Lab Invest (1979) 1.35
Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34
Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol (1993) 1.33
A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol (1998) 1.30
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Etiology of chronic renal failure in Turkish children. Pediatr Nephrol (1995) 1.27
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol (1995) 1.25
Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol (1997) 1.22
Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood (1988) 1.19
In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology (1998) 1.19
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol (2001) 1.18
Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16
Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis (1996) 1.16
Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. Lab Invest (1988) 1.15
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol (1995) 1.15
An update on donor-derived disease transmission in organ transplantation. Am J Transplant (2011) 1.15
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. Am J Transplant (2007) 1.13
Detection of hepatitis C virus RNA using ligation-dependent polymerase chain reaction in formalin-fixed, paraffin-embedded liver tissues. Am J Pathol (1996) 1.12
Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol (1983) 1.12
Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut (2003) 1.12
Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med (1985) 1.11
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11
Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11
Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol (1986) 1.10
Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol (2007) 1.10
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08
Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology (1997) 1.08
Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies. Proc Natl Acad Sci U S A (1980) 1.07
A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics (2000) 1.07
Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol (1981) 1.07
Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr (2000) 1.07
Endovascular treatment of arteriovenous fistulas complicating percutaneous renal biopsy in three paediatric cases. Nephrol Dial Transplant (1999) 1.06
Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation. Mol Ther (2000) 1.05
FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology (1991) 1.05
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03
Improving adherence to medications in pediatric liver transplant recipients. Pediatr Transplant (2008) 1.03
Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid? Eur J Surg Oncol (2007) 1.02
Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology (1983) 1.02
Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol (1995) 1.02
Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. Arch Pathol Lab Med (1989) 1.01
Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. Clin Cancer Res (2001) 1.01
Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA. Cancer Res (1981) 0.99
Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation (1996) 0.99
Primary renal carcinoid. Arch Pathol Lab Med (1990) 0.99
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant (2006) 0.99
Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol (1989) 0.99
A simple new formula to assess liver weight. Transplant Proc (2003) 0.98
Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. Mol Ther (2001) 0.98
Non-adherence in pediatric liver transplant recipients--an assessment of risk factors and natural history. Pediatr Transplant (2000) 0.98
Causes of death in autopsied liver transplantation patients. Mod Pathol (1998) 0.98